Literature DB >> 21656032

Preparation of sulfonated porous carbon nanotubes/activated carbon composite beads and their adsorption of low density lipoprotein.

Yuemei Lu1, Qianming Gong, Fangping Lu, Ji Liang, Lijun Ji, Qingdong Nie, Xiumei Zhang.   

Abstract

The high level of low density lipoprotein (LDL) in plasma is the main cause of atherosclerosis. Hemoperfusion is an ideal therapy to lower the level of LDL in human blood system while therapeutic effect is determined by the adsorbent. The adsorbent must have suitable pore structure and specific functional groups. Carbon nanotubes (CNTs) could be a new adsorbent material because CNTs have high specific surface area and they can be modified by a variety of functional groups. Porous carbon composite beads with the CNTs and phenolic resin mixture were synthesized by suspension polymerization, following with carbonization and steam-activation. Then the porous composite beads were sulfonated with a sulfanilic acid anhydrous by diazotization and coupling reaction. The potential application of the sulfonated porous composite beads in adsorbing low density lipoprotein (LDL) from human serum was investigated. The results showed that the sulfonic acid groups on the composite beads could lower LDL levels greatly by electrostatic interaction with electropositive LDL. The higher 20-100 nm pore volume the composite beads had, the more LDL they could adsorb. The 20-100 nm pore volume was enhanced by adding more CNTs and improving CNTs dispersion (ultrasonic crushing). The sulfonated composite beads containing 45 wt% CNTs presented the highest adsorption capacity to LDL 10.46 mg/g, showing a good prospect as LDL adsorbent in hemoperfusion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21656032     DOI: 10.1007/s10856-011-4368-6

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  20 in total

1.  Assessing the in vitro biocompatibility of a novel carbon device for the treatment of sepsis.

Authors:  Susan R Sandeman; Carol A Howell; Gary J Phillips; Andrew W Lloyd; J Graham Davies; Sergey V Mikhalovsky; Steve R Tennison; Andrew P Rawlinson; Oleksandr P Kozynchenko; Hannah L H Owen; John D S Gaylor; Jennifer J Rouse; James M Courtney
Journal:  Biomaterials       Date:  2005-12       Impact factor: 12.479

2.  Biomedicine. Lowering LDL--not only how low, but how long?

Authors:  Michael S Brown; Joseph L Goldstein
Journal:  Science       Date:  2006-03-24       Impact factor: 47.728

3.  Inflammatory cytokine removal by an activated carbon device in a flowing system.

Authors:  Susan R Sandeman; Carol A Howell; Sergey V Mikhalovsky; Gary J Phillips; Andrew W Lloyd; J Graham Davies; Stephen R Tennison; Anthony P Rawlinson; Oleksaudr P Kozynchenko
Journal:  Biomaterials       Date:  2008-01-22       Impact factor: 12.479

4.  Low density lipoprotein hemoperfusion by direct adsorption of lipoproteins from whole blood (DALI apheresis): clinical experience from a single center.

Authors:  T Bosch; A Lennertz; B Kordes; W Samtleben
Journal:  Ther Apher       Date:  1999-08

5.  Mesoporous carbide-derived carbon for cytokine removal from blood plasma.

Authors:  Saujanya Yachamaneni; Gleb Yushin; Sun-Hwa Yeon; Yury Gogotsi; Carol Howell; Susan Sandeman; Gary Phillips; Sergey Mikhalovsky
Journal:  Biomaterials       Date:  2010-03-19       Impact factor: 12.479

6.  A novel amphiphilic adsorbent for the removal of low-density lipoprotein.

Authors:  Shenqi Wang; Yaoting Yu; Tao Cui; Yan Cheng
Journal:  Biomaterials       Date:  2003-07       Impact factor: 12.479

7.  Polyaniline-carbon nanotube composite film for cholesterol biosensor.

Authors:  Chetna Dhand; Sunil K Arya; Monika Datta; B D Malhotra
Journal:  Anal Biochem       Date:  2008-09-15       Impact factor: 3.365

8.  Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and Lipidfiltration.

Authors:  Ulrich Julius; Klaus G Parhofer; Andreas Heibges; Stefan Kurz; Reinhard Klingel; Hans-Christian Geiss
Journal:  J Clin Apher       Date:  2007       Impact factor: 2.821

9.  In vitro, in vivo studies of a new amphiphilic adsorbent for the removal of low-density lipoprotein.

Authors:  Yan Cheng; Shenqi Wang; Yaoting Yu; Yi Yuan
Journal:  Biomaterials       Date:  2003-06       Impact factor: 12.479

10.  Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging, and Body Composition study.

Authors:  Paul Holvoet; Tamara B Harris; Russell P Tracy; Peter Verhamme; Anne B Newman; Susan M Rubin; Eleanor M Simonsick; Lisa H Colbert; Stephen B Kritchevsky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-06-05       Impact factor: 8.311

View more
  2 in total

1.  Recyclable heparin and chitosan conjugated magnetic nanocomposites for selective removal of low-density lipoprotein from plasma.

Authors:  Jinghua Li; Yanhua Hou; Xiuyong Chen; Xingwei Ding; Yun Liu; Xinkun Shen; Kaiyong Cai
Journal:  J Mater Sci Mater Med       Date:  2014-01-07       Impact factor: 3.896

2.  Ultraefficiently Calming Cytokine Storm Using Ti3C2T x MXene.

Authors:  Tianyi Wang; Xiaoyu Sun; Xin Guo; Jinqiang Zhang; Jian Yang; Shouxuan Tao; Jun Guan; Lin Zhou; Jie Han; Chengyin Wang; Hang Yao; Guoxiu Wang
Journal:  Small Methods       Date:  2021-01-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.